Heptanoic acid,7-[(3-chloro-6,11-dihydro-6-methyl-5,5-dioxidodibenzo[c,f][1,2]thiazepin-11-yl)amino]-,sodium salt (1:1) (30123-17-2)

Identification
Name:	Heptanoic acid,7-[(3-chloro-6,11-dihydro-6-methyl-5,5-dioxidodibenzo[c,f][1,2]thiazepin-11-yl)amino]-,sodium salt (1:1)
Synonyms:	Heptanoicacid, 7-[(3-chloro-6,11-dihydro-6-methyl-5,5-dioxidodibenzo[c,f][1,2]thiazepin-11-yl)amino]-,monosodium salt (9CI);Dibenzo[c,f][1,2]thiazepine, heptanoic acidderiv.;Sodium7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoateS,S-dioxide;Stablon;Tianeptine sodium;
CAS:	30123-17-2
EINECS:	250-059-3
Molecular Formula:	C21H24ClN2NaO4S
Molecular Weight:	458.93
InChI:	InChI=1/C21H27ClN2O4S.Na/c1-24-18-9-6-5-8-16(18)21(23-13-7-3-2-4-10-20(25)26)17-12-11-15(22)14-19(17)29(24,27)28;/h5-6,8-9,11-12,14,21,23,27-28H,2-4,7,10,13H2,1H3,(H,25,26);/q;+1/p-2
Molecular Structure:
Properties
Melting Point:	1800C
Density:	1.38 g/cm³
Appearance:	solid
Biological Activity:	Selective facilitator of 5-HT uptake in vitro and in vivo . Has no affinity for a wide range of receptors, including 5-HT and dopamine (IC 50 > 10 μ M) and has no effect on noradrenalin or dopamine uptake. Antidepressant, analgesic and neuroprotective following systemic administration in vivo .
Usage:	Tricyclic compound with psychostimulant, anti-ulcer and anti-emetic properties. Antidepressant
Safety Data